Lobbying client · LD-2 disclosures
Astrazeneca Pty Limited
Australia
4 filings from 1 registrant · 2014–2015 · latest filed Jul 30, 2015
Reported on its behalf
$19K
every LD-2 on file
Its own filed spend
$0
lobbying for itself
Fees to outside firms
$19K
across every firm on file
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who lobbies for them
Every outside firm that has filed on this client's behalf, by fees reported.
Reading this · LD-2 reports a hired firm's fee and a registrant's reported expenses on separate lines and never both on one filing, so the two lists above are different quantities and are ranked separately rather than against each other. Firm names link to their own record as the firms chapter lands.
What they lobby on
Issue areas declared on the filings, ranked by how many filings name each one.
Copyright/Patent/Trademark
CPT
3 filings
$19K on those filings
Health Issues
HCR
3 filings
$19K on those filings
Pharmacy
PHA
Who did the lobbying
Every lobbyist named on this client's filings.
- Nicholas Campbell Capitalhill Advisory4 filingsthrough 2015
The filings
Every filing on record. Each row links to its full disclosure.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: astrazeneca-pty-limited.